Burkholderia pyrrocinia in cystic fibrosis lung transplantation: a case report

Transplant Proc. 2014 Jan-Feb;46(1):295-7. doi: 10.1016/j.transproceed.2013.08.108.

Abstract

Infection with Burkholderia species is typically considered a contraindication leading to transplantation in cystic fibrosis (CF). However, the risks posed by different Burkholderia species on transplantation outcomes are poorly defined. We present the case of a patient with CF who underwent lung transplantation due to a severe respiratory failure from chronic airways infection with Burkholderia pyrrocinia (B. cepacia genomovar IX) and pan-resistant Pseudomonas aeruginosa. The postoperative course was complicated by recurrent B. pyrrocinia infections, ultimately lea ding to uncontrollable sepsis and death. This is the first case report in CF of Burkholderia pyrrocinia infection and lung transplantation, providing further evidence of the high risk nature of the Burkholderia species.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Burkholderia Infections / diagnostic imaging
  • Burkholderia Infections / metabolism*
  • Burkholderia*
  • C-Reactive Protein / metabolism
  • Cystic Fibrosis / diagnostic imaging
  • Cystic Fibrosis / microbiology*
  • Cystic Fibrosis / surgery*
  • Female
  • Humans
  • Lung Transplantation*
  • Postoperative Period
  • Risk
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • C-Reactive Protein